Physician profile
Tenley Noone
NPI 1679880231
$1,379.82
in general payments reported to CMS, 2019-2025
15 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.45 · 2022: $130 · 2023: $672 · 2024: $356 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Travel and Lodging: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.60 |
| Travel and Lodging | $138.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $524.40 | 2023-2024 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Novo Nordisk INC | $210.30 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $162.05 | 2023-2024 | |
| Lilly USA, LLC | $103.40 | 2021-2023 | Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $80.64 | 2022-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $63.27 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $35.71 | 2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $35.55 | 2021-2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $34.15 | 2025 | |
| Pfizer INC. | $32.31 | 2023 | |
| Merck Sharp & Dohme LLC | $31.38 | 2025 | Verquvo |
| Amgen INC. | $21.21 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.27 | 2023 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $14.63 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tenley Noone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.